Budai Irgalmasrendi Korhaz Nonprofit Kft. — Clinical Trial Site

9 Registered trials

1 Currently recruiting

Organisation

Budai Irgalmasrendi Korhaz Nonprofit Kft.

Location

Budapest, Hungary

Identifier

ORG-100041894

Address

Frankel Leo Ut 17-19, Kerulet, 1027, Hungary

Departments

#348003:Ortopédia
Klinikai Farmakológia
N/A
NA
Ortopédia
Reumatologiai Centrum
Rheumatology

Clinical trials at this site (9)

Search interface

A study of MK-7240/PRA023 in patients with Systemic Sclerosis Associated with Interstitial Lung Disease Recruiting

2023-509743-27-00 Systemic sclerosis associated with interstitial lung di 4 2022-04-29
A Phase 2b to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With ACPA-Positive Rheumatoid Arthritis Ended

2024-515973-82-00 ACPA-Positive Rheumatoid Arthritis 4 2025-06-23
A Phase 3b/4 Randomized, Double-Blind, Double-Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib V… Ended

2022-502578-18-00 Rheumatoid Arthritis 11 2023-11-07
Subcutaneous Anifrolumab in Adult Patients with Systemic Lupus Erythematosus Ended

2024-513031-24-00 Moderate-to-severe Systemic Lupus Erythematosus (SLE) 10 2021-10-22
A trial to learn how well REGN7508 works for preventing blood clots after a knee replacement in adult participants Ended

2023-508602-14-00 Thromboembolic disease 4 2024-06-27
A Phase 2a Multicenter, Randomized, Double Blind, Parallel, Proof of concept Study Evaluating the Efficacy and Safety of Nipocalimab and Cer… Ended

2023-504045-31-00 Rheumatoid Arthritis 4 2024-02-08
A trial to learn how well REGN9933 works for preventing blood clots after knee replacement surgery in adult participants Ended

2022-501470-18-00 Thromboembolic disease 4 2023-06-26
Evaluation of upadacitinib in adult subjects with axial spondyloarthritis Ended

2022-501018-78-00 Axial Spondyloarthritis 5 2020-03-23
A Phase 2a multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Burfiralimab (hzVSF-v13)… Ended

2023-507944-35-00 rheumatoid arthritis 4